Article

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals

2021-05-27

Abstract excerpt

The SARS-CoV-2 B.1.617 lineage emerged in October 2020 in India 1–6 . It has since then become dominant in some indian regions and further spread to many countries. The lineage includes three main subtypes (B1.617.1, B.1617.2 and B.1.617.3), which harbour diverse Spike mutations in the N-terminal domain (NTD) and the receptor binding domain (RBD) which may increase their immune evasion potential. B.1.617.2 is bel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 81fe6d68-62e0-5029-afc9-10a6f2091a5b
DOI: 10.1101/2021.05.26.445838

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individualsDOI 10.1101/2021.05.26.445838Read

SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodiesSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthroughSemantic proximity Read

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationSemantic proximity Read

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Semantic proximity Read

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152Semantic proximity Read

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodiesSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionSemantic proximity Read

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.Semantic proximity Read

Evasion of neutralizing antibodies by Omicron sublineage BA.2.75Semantic proximity Read

Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineageSemantic proximity Read

SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough InfectionSemantic proximity Read

Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico ApproachSemantic proximity Read